Evidence map›Paper›PMID 35991473›Full record

ArticleCanadian liver journal2021

Striving toward hepatitis C elimination in the era of COVID-19.

Charlotte Lanièce Delaunay, Zoë R Greenwald, Nanor Minoyan, Andreea Adelina Artenie, Dahn Jeong, Gayatri Marathe, Yasmin A Saeed, Gillian Kolla, Rasika D Kunden, Chisom Ifeoma Adaeze Okwor and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian liver journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Charlotte Lanièce DelaunayDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.
Zoë R GreenwaldDivision of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Nanor MinoyanCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Andreea Adelina ArteniePopulation Health Sciences, University of Bristol, Bristol, United Kingdom.
Dahn JeongSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Gayatri MaratheDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.
Yasmin A SaeedLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Gillian KollaCanadian Centre for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Rasika D KundenDepartment of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Chisom Ifeoma Adaeze OkworDepartment of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Hannah L WallaceDivision of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Andrew MendlowitzInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Ching-Hsuan LiuDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
Sabrina MazouzDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
Simmone D'souzaDepartment of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Catia Taniela PercianiSoham and Shaila Ajmera Family Transplant Centre, Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
Marylin RheaultDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Michael A PalmerDepartment of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Adam PalayewDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
Mohamed N AbdelnabiCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Evan B CunninghamKirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19hepatitis C eliminationpeople who use drugs Author Affiliationpriority populationsSARS-CoV-2

Identifiers

PMID35991473
PMCPMC9203169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.